| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6433A42F4F |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C52H72GdN5O14 |
| Molecular Weight | 1148.42 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasm Metastasis | 3 | D009362 | ClinicalTrials |
| Brain Neoplasms | 3 | D001932 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Adenocarcinoma | 2 | D000230 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Urogenital Neoplasms | 2 | D014565 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Gallbladder Neoplasms | 1 | D005706 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Oligodendroglioma | 1 | D009837 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 246252-06-2 |
| ChEMBL | CHEMBL3544910 |
| FDA SRS | 6433A42F4F |
CONTENTS